LLL-3, a STAT3 inhibitor, represses BCR-ABL-positive cell proliferation, activates apoptosis and improves the effects of Imatinib mesylate

✍ Scribed by Andre Luiz Mencalha; B. Du Rocher; D. Salles; R. Binato; E. Abdelhay

• Book ID: 105993254
• Publisher: Springer
• Year: 2009
• Tongue: English
• Weight: 522 KB
• Volume: 65
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-009-1109-3